Advertisement
Screener

CENTENE CORPORATION (CNC) Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain

3.0 / 5 stars · 72/120 Roast Me

CENTENE CORPORATION Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain

CENTENE CORPORATION (CNC) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.

Financial Statements › Income Statement › Other Income

us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain · last filed 2025-02-18

  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2022-12-31 was $0.00.
  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2021-12-31 was $0.00.
  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2021-09-30 was $309.00M.
  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2024 was $0.00.
  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2022 was $2.00M, a 99.35% decline from fiscal 2021.
  • CENTENE CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2021 was $309.00M.
Period endBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 3 monthBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 6 monthBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 monthBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 12 month
2024-12-31$0.00
10-K · filed 2025-02-18
2023-12-31$0.00
10-K · filed 2025-02-18
2023-06-30$0.00
10-Q · filed 2023-07-28
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18
$0.00
derived: sum of 2 quarters · filed 2025-02-18
$2.00M
10-K · filed 2025-02-18
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25
$2.00M
10-Q · filed 2022-10-25
2022-06-30$2.00M
10-Q · filed 2023-07-28
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20
$309.00M
derived: sum of 2 quarters · filed 2024-02-20
$309.00M
10-K · filed 2024-02-20
2021-09-30$309.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25
$309.00M
10-Q · filed 2022-10-25
2021-06-30$0.00
10-Q · filed 2022-07-26
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
$0.00
10-K · filed 2023-02-21
2020-09-30$0.00
10-Q · filed 2021-10-26
2019-12-31$0.00
10-K · filed 2022-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
HUMANA INC (HUM)United States$45.651B18.44
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
Cigna Group (CI)United States$70.160B10.44
Elevance Health, Inc. (ELV)United States$86.364B16.90
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62